Literature DB >> 26021276

Current attitudes to breast reconstruction surgery for women at risk of post-mastectomy radiotherapy: A survey of UK breast surgeons.

Paula J Duxbury1, Ashu Gandhi2, Cliona C Kirwan2, Yogesh Jain2, James R Harvey2.   

Abstract

Decision-making for women requiring reconstruction and post-mastectomy radiotherapy (PMRT) includes oncological safety, cosmesis, patient choice, potential delay/interference with adjuvant treatment and surgeon/oncologist preference. This study aimed to quantitatively assess surgeons' attitudes and perceptions about reconstructive options in this setting, and to ascertain if surgical volume influenced advice given. A questionnaire was sent to surgical members of the UK Association of Breast Surgery (ABS) in March-June 2014. The questionnaire elicited information on surgeon volume, reconstructive practice and drivers influencing decision-making. Response rate was 42% (148/355), representing 71% of UK breast units. Delayed breast reconstruction (DBR) was offered more commonly than immediate implant, delayed-immediate or immediate autologous reconstruction (p < 0.05). Cosmesis was thought to be equivalent between IBR and DBR by 15% of surgeons, and 26% believe IBR and DBR offer similar Health-related Quality of Life (HRQoL). Surgeon volume had no effect on reconstruction choice. Common decision-making drivers included negative effects of radiotherapy upon reconstructive and cosmetic outcome. The majority of surgeons (77%) believe the current evidence base is insufficient to guide decision-making. Despite surgeons believing that cosmesis and quality of life are not equivalent between IBR and DBR, DBR remains the commonest approach to this difficult clinical scenario. Surgeons perceive they are using a variety of newer techniques such as Delayed-Immediate Reconstruction and Acellular Dermal Matrices to try to ameliorate the effects of PMRT. This survey demonstrates that there is wide variation in reported surgical practice in this difficult setting. There is widespread acknowledgement of the lack of evidence to guide decision-making.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Breast reconstruction; Mastectomy; Radiotherapy; Reconstructive surgical procedures

Mesh:

Year:  2015        PMID: 26021276     DOI: 10.1016/j.breast.2015.05.002

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  6 in total

1.  The iBRA-2 (immediate breast reconstruction and adjuvant therapy audit) study: protocol for a prospective national multicentre cohort study to evaluate the impact of immediate breast reconstruction on the delivery of adjuvant therapy.

Authors:  Rajiv Dave; Rachel O'Connell; Tim Rattay; Zoe Tolkien; Nicola Barnes; Joanna Skillman; Paula Williamson; Elizabeth Conroy; Matthew Gardiner; Adrian Harnett; Ciara O'Brien; Jane Blazeby; Shelley Potter; Chris Holcombe
Journal:  BMJ Open       Date:  2016-10-07       Impact factor: 2.692

2.  The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study.

Authors:  Rachel L O'Connell; Tim Rattay; Rajiv V Dave; Adam Trickey; Joanna Skillman; Nicola L P Barnes; Matthew Gardiner; Adrian Harnett; Shelley Potter; Chris Holcombe
Journal:  Br J Cancer       Date:  2019-03-29       Impact factor: 7.640

3.  Protocol for a mixed-method study to inform the feasibility of undertaking a large-scale multicentre study comparing the clinical and patient-reported outcomes of oncoplastic breast conservation as an alternative to mastectomy with or without immediate breast reconstruction in women unsuitable for standard breast-conserving surgery (the ANTHEM Feasibility Study).

Authors:  Charlotte Davies; Christopher Holcombe; Joanna Skillman; Lisa Whisker; William Hollingworth; Carmel Conefrey; Nicola Mills; Paul White; Charles Comins; Douglas Macmillan; Patricia Fairbrother; Shelley Potter
Journal:  BMJ Open       Date:  2021-04-16       Impact factor: 2.692

4.  Breast Reconstruction Does Not Affect the Survival of Patients with Breast Cancer Located in the Central and Nipple Portion: A Surveillance, Epidemiology, and End Results Database Analysis.

Authors:  Mingchen Xiong; Zeming Liu; Wenchang Lv; Chongru Zhao; Yichen Wang; Yufang Tan; Qi Zhang; Yiping Wu; Hong Zeng
Journal:  Front Surg       Date:  2022-05-17

5.  External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort.

Authors:  Tim Rattay; Petra Seibold; Miguel E Aguado-Barrera; Manuel Altabas; David Azria; Gillian C Barnett; Renée Bultijnck; Jenny Chang-Claude; Ananya Choudhury; Charlotte E Coles; Alison M Dunning; Rebecca M Elliott; Marie-Pierre Farcy Jacquet; Sara Gutiérrez-Enríquez; Kerstie Johnson; Anusha Müller; Giselle Post; Tiziana Rancati; Victoria Reyes; Barry S Rosenstein; Dirk De Ruysscher; Maria C de Santis; Elena Sperk; Hilary Stobart; R Paul Symonds; Begoña Taboada-Valladares; Ana Vega; Liv Veldeman; Adam J Webb; Catharine M West; Riccardo Valdagni; Christopher J Talbot
Journal:  Front Oncol       Date:  2020-10-30       Impact factor: 6.244

Review 6.  The Journey of Prepectoral Breast Reconstruction through Time.

Authors:  Sharat Chopra; Zaid Al-Ishaq; Raghavan Vidya
Journal:  World J Plast Surg       Date:  2021-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.